Ryan Neal D
University of Pittsburgh Medical Center, Pittsburgh, PA15213, USA.
Lancet. 2005;366(9489):933-40. doi: 10.1016/S0140-6736(05)67321-7.
Depressive disorders during youth occur frequently, are chronic and recurrent, and are associated with significant functional impairment, morbidity, and mortality. Two psychotherapeutic approaches-cognitive behavioural therapy and interpersonal therapy-are each better than wait-list or treatment-as-usual approaches. Several antidepressants have proven efficacious compared with placebo; however, more than half the studies comparing antidepressant treatment with placebo in children and adolescents with depression have not shown any benefit of the active compounds. Suicide rates are decreasing overall in adolescents, and there seems to be a correlation between the use of selective serotonin reuptake inhibitors (SSRIs) and a decrease in completed suicide. However, there was a signal for increase in suicide attempts and suicidal ideation in patients on acute antidepressant treatment when all antidepressants were assessed as a single group. Thus, there is substantial debate about the best approach to treat this serious disorder. Here, we discuss the treatment options for depression in children and adolescents.
青少年抑郁症发病率高,具有慢性复发性,会导致严重的功能障碍、发病和死亡。两种心理治疗方法——认知行为疗法和人际疗法——都比等待名单或常规治疗方法效果更好。与安慰剂相比,几种抗抑郁药已被证明有效;然而,在儿童和青少年抑郁症患者中,超过一半将抗抑郁药治疗与安慰剂进行比较的研究并未显示活性化合物有任何益处。青少年的自杀率总体呈下降趋势,选择性5-羟色胺再摄取抑制剂(SSRI)的使用与自杀未遂减少之间似乎存在关联。然而,当将所有抗抑郁药作为一个整体评估时,接受急性抗抑郁药治疗的患者自杀未遂和自杀意念有增加的迹象。因此,对于治疗这种严重疾病的最佳方法存在大量争议。在此,我们讨论儿童和青少年抑郁症的治疗选择。